GABAergic
Research indicates Selank modulates GABAergic neurotransmission, including GABA-A receptor activity and expression of GABAergic system components. This mechanism is associated with the anxiolytic effects observed in preclinical animal models and early clinical studies, without the sedative or dependency concerns seen with classical benzodiazepines.
- Modulates GABA-A receptor subunit expression
- Anxiolytic effects without benzodiazepine-type sedation
- No reported physical dependence in preclinical models



